$IMVT
Immunovant, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$36.95
▼-1.86%-$0.700
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateImmunovant, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is IMVT down today? It is at $36.95 (-1.86%), and our scanner flagged it 95 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IMVT spikes, and full due diligence on IMVT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IMVT 95 times in the last 30 days. Create a free account to track $IMVT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IMVT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMVT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Pande Atul Director | Sold (automatic/other) | -2K | sold 1.3% | 117K | $65K at $43.27 | Aug 28, 26 |
Pande Atul Director | Other | 2K | added 1.3% | 118K | $13K at $8.43 | Aug 28, 26 |
Gloria Melanie Officer | Sold (automatic/other) | -3K | sold 1.4% | 219K | $135K at $44.16 | Aug 20, 26 |
Pande Atul Director | Sold (automatic/other) | -2K | sold 1.3% | 117K | $60K at $39.80 | Jul 24, 26 |
Pande Atul Director | Other | 2K | added 1.3% | 118K | $13K at $8.43 | Jul 24, 26 |
Stout Jay S Officer | Sold (automatic/other) | -3K | sold 1.4% | 205K | $111K at $38.69 | Jul 23, 26 |
Girao Tiago Officer | Sold (automatic/other) | -7K | sold 2.7% | 241K | $263K at $38.69 | Jul 23, 26 |
Stout Jay S Officer | Sold (automatic/other) | -3K | sold 1.6% | 208K | $138K at $39.53 | Jul 8, 26 |
Van Tuyl Christopher Officer | Sold (automatic/other) | -1K | sold 0.7% | 179K | $48K at $39.53 | Jul 8, 26 |
Gloria Melanie Officer | Sold (automatic/other) | -2K | sold 0.9% | 222K | $80K at $39.53 | Jul 8, 26 |
Venker Eric Officer | Sold (automatic/other) | -3K | sold 1.2% | 254K | $119K at $38.48 | Jul 2, 26 |
Venker Eric Officer | Sold (automatic/other) | -87K 0.04% of company | sold 25% | 257K | $3.3M at $38.14 | Jul 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on IMVT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMVT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
IMVT last traded at $36.95, down 1.86% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Immunovant, Inc. Common Stock (IMVT) is next expected to report earnings on Monday, November 9, 2026, about 50 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IMVT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMVT 95 times in the last 30 days.
IMVT (Immunovant, Inc. Common Stock) trades on XNAS, with a market cap of about $7.63B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMVT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IMVT discussion
Sign in to ask a question or join the discussion.